Literature DB >> 9928415

Genes involved in the control of cellular proliferative potential.

R R Reddel1.   

Abstract

Evidence that control of cellular proliferative potential may be linked to telomere length, along with data indicating that other factors may also be involved, will be reviewed. According to the telomere hypothesis of senescence, the sequential loss of telomeric repeat DNA that occurs during the replication of normal somatic cells eventually dictates the onset of the permanently nonreplicative state known as senescence. Many immortalized cells express telomerase, a ribonucleoprotein enzyme that replaces the telomeric DNA that would otherwise be lost due to replication. However, some immortalized human cells may avoid telomeric shortening without using telomerase. The mechanism involved is currently unknown, but other eukaryotes are able to replace telomeric DNA through (1) recombination and copy switching or (2) retrotransposition. Human fibroblasts that lose p53 function proliferate a limited number of times beyond the population-doubling level at which their normal counterparts become senescent. Lack of functional retinoblastoma (Rb) protein (or equivalent events, such as loss of p16INK4 function, resulting in abrogation of Rb regulatory activity) also permits a temporary extension of proliferative potential. The p53 and pRb effects are additive, indicating that they exert their control on proliferative potential separately. The temporary life span extension associated with loss of p53 and/or Rb pathway function is accompanied by continued telomere shortening. The proliferation arrest that eventually ensues in p53-minus cells or in p53-minus/Rb-minus cells may be regarded as terminal proliferation arrest states serving as a backup to senescence. p53-minus/Rb-minus cells cannot proliferate further unless they acquire the ability to prevent telomeric shortening. Somatic cell hybridization and microcell-mediated chromosome transfer experiments indicate that immortalization involves the loss of function of other, as yet unidentified, genes; some of these may normally repress telomerase expression in somatic cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928415     DOI: 10.1111/j.1749-6632.1998.tb09887.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Molecular mechanisms of H. pylori associated gastric carcinogenesis.

Authors:  Zun-Wu Zhang; Michael JG Farthing
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  Expression of T-STAR gene is associated with regulation of telomerase activity in human colon cancer cell line HCT-116.

Authors:  Ling Zhang; Lian Guo; Yong Peng; Bing Chen
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

Review 3.  The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer.

Authors:  Karen J Meaburn; Christopher N Parris; Joanna M Bridger
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

4.  A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.

Authors:  D P O'Connor; E W Kay; M Leader; G M Murphy; G J Atkins; M J Mabruk
Journal:  Mol Pathol       Date:  2001-06

5.  Distinct patterns of gene expression induced by viral oncogenes in human embryonic brain cells.

Authors:  Piruz Nahreini; Cynthia Andreatta; Bipin Kumar; Amy Hanson; Judith Edwards-Prasad; Curt R Freed; Kedar N Prasad
Journal:  Cell Mol Neurobiol       Date:  2003-02       Impact factor: 5.046

6.  c-Myc-mediated genomic instability proceeds via a megakaryocytic endomitosis pathway involving Gp1balpha.

Authors:  Youjun Li; Jie Lu; Edward V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

7.  Transcription of the Tumor Suppressor Genes p53 and RB in Lymphocytes from Patients with Chronic Kidney Disease: Evidence of Molecular Senescence?

Authors:  Vasileios Kordinas; Chryssoula Nicolaou; George Tsirpanlis; Anastasios Ioannidis; Sotiris Bersimis; Nikos Sabanis; Eleni Fragou; Konstantina Tsiolaki; Stylianos Chatzipanagiotou
Journal:  Int J Nephrol       Date:  2012-09-23

8.  Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.

Authors:  Carmela De Marco; Carmelo Laudanna; Nicola Rinaldo; Duarte Mendes Oliveira; Maria Ravo; Alessandro Weisz; Michele Ceccarelli; Elvira Caira; Antonia Rizzuto; Pietro Zoppoli; Donatella Malanga; Giuseppe Viglietto
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.